Found: 137
Select item for more details and to access through your institution.
Categorisation of continuous risk factors in epidemiological publications: a survey of current practice.
- Published in:
- Epidemiologic Perspectives & Innovations, 2010, v. 7, p. 9, doi. 10.1186/1742-5573-7-9
- By:
- Publication type:
- Article
Predictors of high-cost hospitalization in the treatment of acute coronary syndrome in Asia: findings from EPICOR Asia.
- Published in:
- 2018
- By:
- Publication type:
- journal article
State of the art in comparative cancer clinical trials.
- Published in:
- Cancer (0008543X), 1987, v. 60, n. 11, p. 2811, doi. 10.1002/1097-0142(19871201)60:11<2811::AID-CNCR2820601136>3.0.CO;2-P
- By:
- Publication type:
- Article
Group sequential methods in the design and analysis of clinical trials.
- Published in:
- Biometrika, 1977, v. 64, n. 2, p. 191
- By:
- Publication type:
- Article
Editorial.
- Published in:
- Human & Experimental Toxicology, 1985, v. 4, n. 5, p. 471, doi. 10.1177/096032718500400501
- By:
- Publication type:
- Article
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement: guidelines for reporting observational studies.
- Published in:
- Bulletin of the World Health Organization, 2007, v. 85, n. 11, p. 867, doi. 10.2471/BLT.07.045120
- By:
- Publication type:
- Article
Ordered Polytomous Regression: An Example Relating Serum Biochemistry and Haematology to Alcohol Consumption.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1986, v. 35, n. 3, p. 289, doi. 10.2307/2348029
- By:
- Publication type:
- Article
Regression Models and Non-proportional Hazards in the Analysis of Breast Cancer Survival.
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1984, v. 33, n. 2, p. 176, doi. 10.2307/2347444
- By:
- Publication type:
- Article
Regression of Area Mortality Rates on Expalanatory Variables: What Weighting is Appropriate?
- Published in:
- Journal of the Royal Statistical Society: Series C (Applied Statistics), 1981, v. 30, n. 3, p. 286, doi. 10.2307/2346353
- By:
- Publication type:
- Article
Empagliflozin, irrespective of blood pressure, improves outcomes in heart failure with preserved ejection fraction: the EMPEROR-Preserved trial.
- Published in:
- European Heart Journal, 2023, v. 44, n. 5, p. 396, doi. 10.1093/eurheartj/ehac693
- By:
- Publication type:
- Article
Effect of empagliflozin on circulating proteomics in heart failure: mechanistic insights into the EMPEROR programme.
- Published in:
- European Heart Journal, 2022, v. 43, n. 48, p. 4991, doi. 10.1093/eurheartj/ehac495
- By:
- Publication type:
- Article
Uric acid and sodium-glucose cotransporter-2 inhibition with empagliflozin in heart failure with reduced ejection fraction: the EMPEROR-reduced trial.
- Published in:
- European Heart Journal, 2022, v. 43, n. 36, p. 3435, doi. 10.1093/eurheartj/ehac320
- By:
- Publication type:
- Article
Empagliflozin and serum potassium in heart failure: an analysis from EMPEROR-Pooled.
- Published in:
- European Heart Journal, 2022, v. 43, n. 31, p. 2984, doi. 10.1093/eurheartj/ehac306
- By:
- Publication type:
- Article
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trials.
- Published in:
- European Heart Journal, 2022, v. 43, n. 7, p. e17, doi. 10.1093/eurheartj/ehz430
- By:
- Publication type:
- Article
Effect of empagliflozin in patients with heart failure across the spectrum of left ventricular ejection fraction.
- Published in:
- European Heart Journal, 2022, v. 43, n. 5, p. 416, doi. 10.1093/eurheartj/ehab798
- By:
- Publication type:
- Article
Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 43, p. 4455, doi. 10.1093/eurheartj/ehab579
- By:
- Publication type:
- Article
Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 43, p. 4442, doi. 10.1093/eurheartj/ehab360
- By:
- Publication type:
- Article
Empagliflozin and health-related quality of life outcomes in patients with heart failure with reduced ejection fraction: the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 13, p. 1203, doi. 10.1093/eurheartj/ehaa1007
- By:
- Publication type:
- Article
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial.
- Published in:
- European Heart Journal, 2021, v. 42, n. 6, p. 671, doi. 10.1093/eurheartj/ehaa968
- By:
- Publication type:
- Article
The win ratio approach for composite endpoints: practical guidance based on previous experience.
- Published in:
- European Heart Journal, 2020, v. 41, n. 46, p. 4391, doi. 10.1093/eurheartj/ehaa665
- By:
- Publication type:
- Article
Combination chemotherapy for metastatic breast carcinoma. Prospective comparison of multiple drug therapy with L-phenylalanine mustard.
- Published in:
- 1976
- By:
- Publication type:
- journal article
The win ratio: a new approach to the analysis of composite endpoints in clinical trials based on clinical priorities.
- Published in:
- European Heart Journal, 2012, v. 33, n. 2, p. 176, doi. 10.1093/eurheartj/ehr352
- By:
- Publication type:
- Article
Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial.
- Published in:
- European Heart Journal, 2010, v. 31, n. 7, p. 824, doi. 10.1093/eurheartj/ehp604
- By:
- Publication type:
- Article
Predictors of mortality and morbidity in patients with chronic heart failure.
- Published in:
- European Heart Journal, 2006, v. 27, n. 1, p. 65, doi. 10.1093/eurheartj/ehi555
- By:
- Publication type:
- Article
Antithrombotic Strategies in Patients With Acute Coronary Syndromes Undergoing Early Invasive Management.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 298, n. 21, p. 2497, doi. 10.1001/jama.298.21.2497
- By:
- Publication type:
- Article
Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
- Published in:
- 2007
- By:
- Publication type:
- journal article
Levosimendan vs Dobutamine for Patients With Acute Decompensated Heart Failure.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 17, p. 1883, doi. 10.1001/jama.297.17.1883
- By:
- Publication type:
- Article
Routine Upstream Initiation vs Deferred Selective Use of Glycoprotein llb/llla Inhibitors in Acute Coronary Syndromes.
- Published in:
- JAMA: Journal of the American Medical Association, 2007, v. 297, n. 6, p. 591, doi. 10.1001/jama.297.6.591
- By:
- Publication type:
- Article
Reporting of Noninferiority and Equivalence Randomized Trials: An Extension of the CONSORT Statement.
- Published in:
- JAMA: Journal of the American Medical Association, 2006, v. 295, n. 10, p. 1152, doi. 10.1001/jama.295.10.1152
- By:
- Publication type:
- Article
When (Not) to Stop a Clinical Trial for Benefit.
- Published in:
- 2005
- By:
- Publication type:
- Editorial
Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes.
- Published in:
- 2006
- By:
- Publication type:
- Case Study
Incremental value of C‐reactive protein to the MEESSI acute heart failure risk score.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 8, p. 1749, doi. 10.1002/ejhf.3349
- By:
- Publication type:
- Article
Insulin‐like growth factor binding protein‐7 concentrations in chronic heart failure: Results from the EMPEROR programme.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 806, doi. 10.1002/ejhf.3227
- By:
- Publication type:
- Article
Body mass index and cardiorenal outcomes in the EMPEROR‐Preserved trial: Principal findings and meta‐analysis with the DELIVER trial.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 900, doi. 10.1002/ejhf.3221
- By:
- Publication type:
- Article
Empagliflozin and risk of lower respiratory tract infection in heart failure with mildly reduced and preserved ejection fraction: An EMPEROR‐Preserved analysis.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 952, doi. 10.1002/ejhf.3180
- By:
- Publication type:
- Article
Early changes in estimated glomerular filtration rate post‐initiation of empagliflozin in EMPEROR‐Preserved.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 885, doi. 10.1002/ejhf.3136
- By:
- Publication type:
- Article
Carbohydrate antigen 125 concentrations across the ejection fraction spectrum in chronic heart failure: The EMPEROR programme.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 4, p. 788, doi. 10.1002/ejhf.3166
- By:
- Publication type:
- Article
Effects of empagliflozin on collagen biomarkers in patients with heart failure: Findings from the EMPEROR trials.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 2, p. 274, doi. 10.1002/ejhf.3101
- By:
- Publication type:
- Article
Growth differentiation factor‐15 and the effect of empagliflozin in heart failure: Findings from the EMPEROR program.
- Published in:
- European Journal of Heart Failure, 2024, v. 26, n. 1, p. 155, doi. 10.1002/ejhf.3078
- By:
- Publication type:
- Article
Health status across major subgroups of patients with heart failure and preserved ejection fraction.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 9, p. 1623, doi. 10.1002/ejhf.2831
- By:
- Publication type:
- Article
Time to clinical benefit of eplerenone among patients with heart failure and reduced ejection fraction: A subgroups analysis from the EMPHASIS‐HF trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1444, doi. 10.1002/ejhf.2952
- By:
- Publication type:
- Article
Liver tests, cardiovascular outcomes and effects of empagliflozin in patients with heart failure and preserved ejection fraction: The EMPEROR‐Preserved trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1375, doi. 10.1002/ejhf.2922
- By:
- Publication type:
- Article
Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: Insights from the EMPEROR‐Preserved trial.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 8, p. 1337, doi. 10.1002/ejhf.2857
- By:
- Publication type:
- Article
Empagliflozin in heart failure with preserved ejection fraction with and without atrial fibrillation.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 7, p. 970, doi. 10.1002/ejhf.2861
- By:
- Publication type:
- Article
The win ratio method in heart failure trials: lessons learnt from EMPULSE.
- Published in:
- European Journal of Heart Failure, 2023, v. 25, n. 5, p. 632, doi. 10.1002/ejhf.2853
- By:
- Publication type:
- Article
Heart failure outcomes according to heart rate and effects of empagliflozin in patients of the EMPEROR‐Preserved trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1883, doi. 10.1002/ejhf.2677
- By:
- Publication type:
- Article
Biomarker‐driven prognostic models in chronic heart failure with preserved ejection fraction: the EMPEROR–Preserved trial.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 10, p. 1869, doi. 10.1002/ejhf.2607
- By:
- Publication type:
- Article
Early changes in estimated glomerular filtration rate post-initiation of empagliflozin in EMPEROR-Reduced.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Outcomes with empagliflozin in heart failure with preserved ejection fraction using DELIVER‐like endpoint definitions.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 8, p. 1400, doi. 10.1002/ejhf.2558
- By:
- Publication type:
- Article
Impact of anaemia and the effect of empagliflozin in heart failure with reduced ejection fraction: findings from EMPEROR‐Reduced.
- Published in:
- European Journal of Heart Failure, 2022, v. 24, n. 4, p. 708, doi. 10.1002/ejhf.2409
- By:
- Publication type:
- Article